An internal look into governance at this marijuana company answers some questions but raises others.
Berkshire Hathaway's biggest sells last quarter might surprise you.
This top marijuana stock reported sales grew at a breakneck pace last quarter, but that may only be the beginning.
Here are Berkshire Hathaway's biggest buys last quarter.
The constipation kingpin reported fourth-quarter results that sparked investor interest.
Here's what you need to know about using spousal benefits to maximize your household's Social Security benefits.
Canada's leading marijuana stock delivered remarkable revenue growth, but skyrocketing costs were a problem.
Marijuana stock investors need to know these facts before buying or selling shares in this top pot stock.
The marijuana stock could be getting itself back on track.
The marijuana stock surged following preliminary fourth-quarter guidance.
Important catalysts at this small-cap Canadian cannabis company could send its shares soaring.
Bear markets are scary, but these tips could help you make the most of the next big tumble in the stock market.
Hemp and marijuana are just different enough for hemp to represent a huge market opportunity for marijuana stocks.
Investors got more disappointing news regarding Sangamo Therapeutics' gene-editing approach this week.
Do these under-the-radar stocks deserve a spot in your growth stock portfolio?
It could be the perfect time to add these fast-growing companies to your portfolio.
Investors rushed to buy shares after the company detailed its latest progress.
Investors hope that its lead drug candidate can make it to the Food and Drug Administration for approval soon.
Canopy Growth is boosting the number of shares it owns in this cannabis investment company.
This cannabis supply company saw its share price skyrocket, in part due to news out of Washington, D.C.